Global Nootropics Market to be Worth USD 5,959 Million By 2024 at a CAGR of around 15.7% – ZMR

Nootropics Market

Nootropics Market

Global Nootropics Market expected to reach approximately USD 5,959 million by 2024, at a CAGR of around 15.7% between 2018 and 2024

Global Nootropics Market expected to reach approximately USD 5,959 million by 2024, at a CAGR of around 15.7% between 2018 and 2024”

— Zion Market Research

NEW YORK, NEW YORK, UNITED STATES, February 20, 2020 /EINPresswire.com/ — Zion Market Research has published a new report titled “Nootropics Market By Application (Memory Enhancement, Mood and Depression, Attention and Focus, Longevity and Anti-Aging, Sleep, Recovery, and Dream Enhancement, and Anxiety): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global nootropics market was valued at around USD 1,324 million in 2017 and is expected to reach approximately USD 5,959 million by 2024, at a CAGR of around 15.7% between 2018 and 2024.

Nootropics are also known as cognitive enhancers or smart drugs. These include supplements, drugs, and other related substances that can advance cognitive function, mainly executive functions, motivation, creativity, memory, or attention in healthy individuals. Nootropics can be synthetic or natural substances that are preferred widely to enhance an individual’s mental performance. Caffeine, L-Theanine, Creatine, Bacopa Monnieri, and Rhodiola Rosea are some of the popularly used nootropics.

Get Free Sample of this Research Report – https://www.zionmarketresearch.com/sample/nootropics-market

The progression of the nootropics market is primarily due to the rising consumer expenditure on healthcare and wellness. Moreover, the growing competition in education and career demands a workforce that is not only competitive but also talented. To gain a competitive advantage, a large number of people globally prefer supplements and smart drugs for improving their concentration and grasping power. This, in turn, is estimated to boost the nootropics market in the near future. The extensive and continually growing list of potential nootropics is predicted to increase the number of prospective consumers within the forecast timeline.

By application, the global nootropics market is classified into mood and depression, memory enhancement, attention and focus, anti-aging and longevity, sleep, recovery and dream enhancement, and anxiety. The memory enhancement is the held a considerable share in terms of revenue in the year 2017, due to a rapidly evolving working environment and the education system that gradually involves workload and mental and physical pressure to succeed. Moreover, the increasing aging population is at risk of suffering from dementia. The attention and focus and mood and depression are other applications. The increasing trend of cognitive enhancement among healthy individuals for professional advantage, personal improvement, academic success, athletic performance, and to sustain brain activities during old age is estimated to boost the demand for nootropic products over the projected timeline.

Browse TOC of this Research Report – https://www.zionmarketresearch.com/toc/nootropics-market

By region, the global nootropics market includes Europe, North America, the Middle East, and Africa, Latin America, and the Asia Pacific. North America contributed a considerable revenue share in 2017, owing to the rising number of consumers spending on health and wellness products. Asia Pacific nootropics market is another important region that is likely to register a considerable rate of growth over the forecast span, due to the increasing penetration of nootropics organizations in China and India. The Latin American market for nootropics is expected to grow owing to growing consumer awareness about the benefits of nootropics. The Middle Eastern and African nootropics market is projected to grow in the years ahead, due to the rise in the number of nootropic manufacturers and distributors in the region.

Some key players of the global nootropics market report are Accelerated Intelligence, Inc., Nootrobox, Inc., AlternaScript LLC, Onnit Labs LLC, Cephalon, Inc., Clarity Nootropics, Peak Nootropics, United Pharmacies, Powder City LLC, Purelife Bioscience Co., Ltd, and SupNootropic Biological Technology Co., Ltd., among others.

This report segments the global nootropics market into:

Global Nootropics Market: Application Analysis

Memory Enhancement
Mood and Depression
Attention and Focus
Longevity and Anti-aging
Sleep, Recovery and Dream Enhancement
Anxiety

Global Nootropics Market: Regional Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Browse more Pharmaceutical Market Research Reports – https://www.zionmarketresearch.com/category/pharmaceutical

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Kalpesh Deshmukh
Zion Market Research
+1 855 465 4651
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Nevada Mesothelioma Victims Center Has Recommended Attorney Erik Karst of The Law Firm of Karst von Oiste to Ensure a Navy Veteran with Mesothelioma in Nevada Receives the Best Compensation Results

"We have endorsed the law firm of Karst von Oiste-KVO and their founding partner Erik Karst to ensure a Navy Veteran or person in Nevada with mesothelioma receives the best compensation results.”

— Nevada Mesothelioma Victims Center

LAS VEGAS, NEVADA, USA, February 20, 2020 /EINPresswire.com/ — The Nevada Mesothelioma Victims Center says, "We have endorsed the law firm of Karst von Oiste-KVO and their founding partner Erik Karst to ensure a Navy Veteran or person in Nevada with mesothelioma receives the best possible financial compensation settlement results. Erik Karst and his amazing team at Karst von Oiste are responsible for over a billion dollars in compensation results for people with mesothelioma and asbestos exposure lung cancer and they make house calls anywhere in Nevada for a person with this rare cancer. For direct access to attorney Erik Karst of the law firm of Karst von Oiste please call us anytime at 800-714-0303." www.karstvonoiste.com/

The Nevada Mesothelioma Victims Center is appealing to a Navy Veteran or a person with mesothelioma in Nevada and or their family members to call them anytime so they do not impulsively end up signing up for 'free' books, kits, guides and calculators because nothing is free. They are also urging a Navy Veteran or person in Nevada to steer clear of local car accident law firms listing as the things they do-mesothelioma compensation claims-because in many instances a law firm like this will need to bring in another law firm to assist with the work. https://Nevada.MesotheliomaVictimsCenter.Com

The Nevada Mesothelioma Victims Center is also offering a vial free service designed to increase the potential financial compensation for a person with mesothelioma. They call this service the 'list' and it is focused on documenting how, where and when a person with mesothelioma was exposed to asbestos. It is this incredibly important information that becomes the basis for a mesothelioma compensation claim as they would be happy to discuss at 800-714-0303. https://Nevada.MesotheliomaVictimsCenter.Com

The Nevada Mesothelioma Victims Center wants to emphasize their unsurpassed services for a diagnosed victim are available statewide anywhere in Nevada including communities such as Las Vegas, Reno, Carson City, Paradise, and Enterprise.

In addition to their focus on making certain all diagnosed victims get the best possible mesothelioma compensation lawyers the Nevada Mesothelioma Victims Center is also focused on the best possible medical treatment options. In the instance of Nevada some of the best possible treatment facilities may be in California, or Utah as the Center would like to explain:

* Comprehensive Cancer Clinic Las Vegas Nevada: https://www.cccnevada.com/

* UCLA Medical Center Los Angeles, California: https://cancer.ucla.edu/

* The Huntsman Cancer Institute Salt Lake City, Utah: https://healthcare.utah.edu/huntsmancancerinstitute/

High-risk work groups for exposure to asbestos in Nevada include Veterans of the US Navy, former power plant workers, shipyard workers, oil refinery workers, steel mill workers, miners, factory workers, miners, plumbers, electricians, auto mechanics, machinists, casino maintenance workers, and construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s, and typically the exposure to asbestos did not occur in Nevada. https://Nevada.MesotheliomaVictimsCenter.Com

According to the CDC the states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Nevada Mesothelioma Victims Center
+1 800-714-0303
email us here


Source: EIN Presswire

Washington US Navy Veterans Lung Cancer Advocate Offers a Navy Veteran with Lung Cancer and Asbestos Exposure in the Service to Call for Direct Access to the Lawyers at Karst von Oiste-Get Compensated

To get the compensation job done for a Navy Veteran or person with lung cancer and who had heavy exposure to asbestos the Advocate has endorsed the lawyers at the law firm of Karst von Oiste. ”

— Washington US Navy Veterans Lung Cancer Advocate

SEATTLE, WASHINGTON , USA, February 20, 2020 /EINPresswire.com/ — The Washington US Navy Veterans Lung Cancer Advocate says, "We are urging a Navy Veteran or person with lung cancer anywhere in Washington who also had heavy to extreme exposure to asbestos in the navy or at work to call us anytime at 800-714-0303. The people we are trying to identify are probably over 60 years old and they may have completely forgotten about their exposure to asbestos when they were much younger. What people like this do not realize is the asbestos compensation trust funds were set up for them too. Financial compensation for a person like this could exceed $100,000." https://Washington.USNavyLungCancer.Com

To get the financial compensation job done for a Navy Veteran or person with lung cancer and who had heavy exposure to asbestos the Advocate has endorsed the amazing lawyers at the law firm of Karst von Oiste. The lawyers at the law firm of Karst von Oiste are responsible for over a billion dollars in financial compensation settlements for people with asbestos exposure lung cancer and or mesothelioma. For direct access to the lawyers at Karst von Oiste please call 800-714-0303-anytime. www.karstvonoiste.com/

The Washington US Navy Veterans Lung Cancer Advocate is offering the following free services for a Navy Veteran or person with asbestos exposure lung cancer in Washington or anywhere in the United States:

* “We will assist with VA Disability payments for Navy Veterans.”

* “We will assist a Navy Veteran or person with asbestos exposure lung cancer get organized about how, where and when they were exposed to asbestos. We call this service the ‘list’ and it is this information that becomes the basis for an asbestos exposure lung cancer compensation claim as we would like to discuss at 800-714-0303." https://Washington.USNavyLungCancer.Com

The Washington US Navy Veterans Lung Cancer Advocate's free services are available to people with asbestos exposure lung cancer or mesothelioma in Seattle, Spokane, Tacoma, Vancouver, Bellevue, Kent, Everett, Renton, Yakima, Federal Way, Bremerton, The Tri Cities, Bellingham or anywhere in Washington State.

High-risk work groups for exposure to asbestos in Washington State include Veterans of the US Navy, hydro-electric power plant workers, shipyard workers in Bremerton, Seattle and Tacoma, nuclear power plant workers including workers at the Hanford Nuclear Site, hydroelectric workers, oil refinery workers, pulp and paper mill workers along Washington’s Coast and Puget Sound, aerospace or commercial airplane factory workers, public utility workers, plumbers, electricians, auto mechanics, machinists, millwrights, insulators, pipefitters, and construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s. www.karstvonoiste.com/

According to the American Cancer Society for nonsmokers who have been exposed to asbestos in their workplace the risk of lung cancer is five times that of unexposed workers. https://www.cdc.gov/cancer/lung/statistics/index.htm.

The US Navy Veterans Lung Cancer Advocate says, "If your husband, dad, coworker or neighbor has just been diagnosed with lung cancer and you know they had significant exposure to asbestos in the navy, at a shipyard or while working at a factory, at power plant, public utility, or as a plumber, electrician welder, mechanic or any kind of skilled trades group in any state please have them call us anytime at 800-714-0303. Most people like this never get compensated-even though the asbestos trust funds were set up for them too. We are trying to change this sad fact." https://USNavyLungCancer.Com

States with the highest incidence of lung cancer include Kentucky, West Virginia, Maine, Tennessee, Mississippi, Ohio, Indiana, Louisiana, Arkansas, Missouri, North Carolina, Rhode Island, Alabama, and Delaware. www.karstvonoiste.com/

For more information about asbestos exposure please visit the NIH's website on this topic: https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-shee

Michael Thomas
Washington US Navy Veterans Lung Cancer Advocate
+1 800-714-0303
email us here


Source: EIN Presswire

Medical Software Market 2020, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2025

A New Market Study, titled “Medical Software Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, February 20, 2020 /EINPresswire.com/ — Summary

A New Market Study, titled “Medical Software Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

This report provides in depth study of “Medical Software Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Medical Software Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This market report offers a comprehensive analysis of the global Medical Software market. This report focused on Medical Software market past and present growth globally. Global research on Global Medical Software Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2019-2025 along with industry size estimates are explained.

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3906907-global-medical-software-market-data-survey-report-2013-2025

Market Overview 
Medical Software have changed the ways health care system works. Through this software, the healthcare providers are not only providing a systematic and time efficient services but also have become capable to recording and maintaining patient data anywhere and anytime. Medical Software has enabled advancement of healthcare solutions and simultaneously improved the care offered to the patients. With software like electronic record management, a lot can be done. The market has witnesses proliferation in the past few years because of exponential growth of demand from the end-users. There have been some driving factors that accelerate the global market, and also a few restraining factors that decelerated growth in the market.

Given how the Medical Software has benefited both the health care service providers, patient, and their families, the Medical Software market will continue to expand and cover more segment and regions. The technologies like internet of things is very likely to improve the Medical Software service that is currently available. As per the forecast, the trend of increased consumption and demand will continue during the forecast period since there has been an increasing number of manufacturers and services providers as well, who are reaching the prospective customers through different channels.

This report focuses on the global top players, covered
eClinicalWorks
McKesson
Cerner Corp
Allscripts
Athena Health
GE Healthcare
Epic Systems Corp
Quest Diagnostics (DELL)
Optum Health
NextGen Healthcare
Practice Fusion
Greenway Health
Carestream Health
Merge Healthcare (IBM)
Sunquest Information Systems
Meditech
Compugroup Medical
Computer Programs and Systems
Lexmark Healthcare
Agfa HealthCare
Neusoft
Winning Health Technology

Market Segmentation 
EHR/EMR Medical Software, Medical CRM Medical Software, and Websites and Patient Portals Medical Software: following are the geographical market segments on the basis of product type and their specification. Since the product has penetrated into different geographical locations, there are also a great number of sub-sections that can be witnessed on deeper analysis of the global market. The product reach is however limited in some regions, depending on the demand and supply rate. Manufacturers offer services as per the demand from the customers. The same market can also be segmented on the basis of end-users and how they are used by different user/sector for different purposes. Global market classification on the basis of end-user are as follows: Medical Software for hospitals, Medical Software for Healthcare Organization, Medical Software for Individual and Others.

Regional Overview 
Europe (Germany, UK, France, Italy, Russia, and Turkey, etc.) and South America (Brazil etc.): following are the regions where product demand has been increasing and it’s where majority of the manufacturers and suppliers’ acquisitions are. Secondary markets with a significant number of service providers or manufacturers and also significant consumption rate are as follow: North America (the United States, Canada, and Mexico) and The Middle East and Africa (North Africa and GCC Countries). Given the increasing world economy, the ever-increasing world population and life-expectancy, following regions are also expanding their user base and there has also been an increasing number of small business startups with distribution in local areas and market. Some of the exponentially growing markets are as follows: Asia-Pacific (China, Japan, Korea, India), Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam)

Industry News 
The usage of social media and internet marketing has increased opportunities for the sellers, and it will continue to do so. The technologies like internet of things is very likely to improve the Medical Software service that is currently available.

Major Key Points in Table of Content

1 Global Market Overview

2 Regional Market

3 Key Manufacturers

4 Major Application

5 Market by Type

6 ConclusionFig Global Medical Software Market Size and CAGR 2013-2018 (Million USD)

Continued….

At Any Query @ https://www.wiseguyreports.com/enquiry/3906907-global-medical-software-market-data-survey-report-2013-2025

Report Summary:
In the first section, the Global Medical Software Market report presents industry overview, definition, and scope. The second part briefs about the Global Medical Software industry bifurcation by Type, Application and Geographical regions. The top industry players, revenue analysis, and sales margin are explained. The production and consumption scenario is specified.

The SWOT analysis by players, the growth rate for each type, application, and the region is covered. A 5-year forecast Global Medical Software industry perspective will lead to profitable business plans and informed moves. Towards, the end data sources, research methodology, and findings are offered.

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+16282580070
email us here


Source: EIN Presswire

Moringa Products Market 2020 Global Share,Trend,Segmentation And Forecast To 2025

WiseGuyReports.Com Publish a New Market Research Report On –“ Moringa Products Market 2020 Global Share,Trend,Segmentation And Forecast To 2025”.

PUNE, INDIA, February 20, 2020 /EINPresswire.com/ —
Moringa Products Market 2020

Description: –

The global moringa products market is projected to expand at a considerable rate over the last few years owing to the health advantages related with the products obtained from the tree. The ever-increasing use of moringa products is changing the number of moringa growers in the market. It is understood to have several advantages and it utilizes variety from health and attraction to helping prevent and cure illnesses. It can be used in various forms such as raw moringa, moringa powder used in food additions, tea and oil. The market is constrained by several issues such as expanding necessity for nutritional additions, improving health understanding among people, and moving focus for natural treatment. Additionally, the requirement for organic-certified moringa products is rising, especially in Europe, which has created opportunities for the growth of the market.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/4657162-global-moringa-products-market-research-report-forecast-to-2025

For more information or any query mail at sales@wiseguyreports.com

Major Key Players Included are:-

The projected onlookers in the Global moringa products market are companies like Organic India Pvt Ltd. (India), Moringa Pura Vida (Mexico), Kuli Kuli, Inc. (US), Only Natural Inc. (US), Grenera Nutrients Pvt Ltd. (India), Aayuritz Phytonutrients Pvt Ltd. (India), Green Virgin Products LLC (US), Dominate Industries (India) and Moringa Initiative Ltd. (South Africa).

The report provides information on the qualitative and quantitative analysis of the Moringa Products market at various levels. The qualitative analysis provides the human-related analysis of the Moringa Products market, whereas quantitative analysis provides the numerical data of the Moringa Products market. The historical market value for the year 2019 is defined in the market report along with the market value for the upcoming year 2020. The research methods like primary research mechanism and secondary research mechanism are used in the market report to research on the global Moringa Products market. The CAGR percentage is also mentioned in the market report for the forecast year 2025. The strategies of the Moringa Products market players are defined in the market report. In addition to that, the past, future and present market data is provided in the Moringa Products market report.

Market Dynamics

The various factors like market trends, market shares, market revenue, production capacity, and others are described in the Moringa Products market report. Changes in the behaviour of customers and manufacturers are defined in the Moringa Products market report. The changing perspectives of the end-users have been highlighted in the market report. The changing perspectives about the Moringa Products market products can change the market trends too. The value and the volume of the Moringa Products market are defined in the market report at global, regional, and company levels. Both the negative and positive changes occurring in the Moringa Products market are defined in the market report. The other infrastructure developments, technological advancements, economic standings of developing nations in the Moringa Products market are also included in the market report.

Market Segmentation

The product types, application, geographical, and company types are four major types of segmentations done on the Moringa Products market at various levels. The segmentation is done to understand the Moringa Products market precisely. The segmentation based on the application provides information on the various applications of different products in the Moringa Products market. The product type segmentation provides the name and description of a variety of products produced in the Moringa Products market at various levels. The regional segmentation is made on the grounds of the study conducted in the local and international Moringa Products market. The regional segmentation provides the names of major countries and key regions where the Moringa Products market is present.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/4657162-global-moringa-products-market-research-report-forecast-to-2025

Table of Contents – Major Key Points

1 Executive Summary

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Moringa Products Market, by Type

7 Global Moringa Products Market, by End Use

8 Global Moringa Products Market, by Region

Continued….

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

CERTOLAB Anuncia Los Servicios de Cumplimiento y Implementación de la NOM-035-STPS-2018 para Empresas

Unidades Medicas Certolab

Unidades Medicas Certolab

Tecnica CERTOLAB

Tecnica CERTOLAB

CERTOLAB Servicios de Audiometria y Diagnósticos

CERTOLAB Servicios de Audiometria y Diagnósticos

Con los servicios preventivos de salud de CERTOLAB, las empresas pueden recebir apoyo en el cumplimiento de la Norma 035.

CIUDAD DE MEXICO, CDMX, MEXICO, February 20, 2020 /EINPresswire.com/ — CERTOLAB Médica, el mejor servicio médico empresarial, se complace en anunciar sus servicios de cumplimiento y implementación de la NOM-035-STPS-2018 para las empresas.

La NOM-035-STPS es una norma que obliga a las empresas a detectar y prevenir los riesgos psicosociales que se puedan presentar en las actividades diarias dentro de una organización. En caso de incumplimiento a esta norma, las multas pueden ser de más de 500 mil pesos.  

Los Factores de Riesgo Psicosocial en el trabajo son los aspectos psicológicos y sociales que pueden afectar negativamente a los trabajadores dentro de una organización. Pueden ser, por ejemplo, estrés grave, ansiedad o trastornos del sueño de acuerdo al tipo de puesto, tipo de jornada laboral o a la exposición a eventos traumáticos severos.

¿Cuáles son las obligaciones del patrón?
Establecer y difundir políticas que fomenten:
-El compromiso de la prevención de los factores de riesgo psicosocial.
-La prevención de la violencia laboral.
-La promoción de un entorno que favorezca el clima laboral.

¿A qué se comprometen los trabajadores en la NOM-035-STPS-2018?
-Seguir todas las medidas de prevención que establezca el patrón para controlar los factores de riesgo psicosocial.
-Evitar prácticas que atenten contra el clima organizacional y que promuevan actos de violencia en el área de trabajo.
-Participar en la identificación de los factores de riesgo psicosocial y en la evaluación del entorno organizacional.

Una de las opciones para identificar los factores que están afectando a tu fuerza laboral es crear una encuesta de clima laboral.

¿Qué elementos contempla la NOM-035-STPS-2018 para evaluar?
Para dar cumplimiento a esta Norma, es importante evaluar aspectos como:
-Condiciones en el ambiente de trabajo.
-Carga laboral.
-Falta de control sobre el trabajo.
-Jornadas de trabajo y rotación de turnos que excedan lo señalado en la Ley Federal Del Trabajo.
-Interferencia en la relación trabajo-familia.

La NOM-035-STPS-2018 obliga a las empresas a tomar todas las medidas de prevención para controlar los factores de riesgo psicosocial, por ejemplo realizando encuestas para empleados que permitan identificar cuáles son los factores de riesgo psicosocial y evaluar el entorno laboral. 

-Entre los principales factores psicosociales que se pueden presentar en el espacio de trabajo se encuentran:
-Violencia Laboral
-Condiciones de riesgo en el ambiente de trabajo
-Condiciones laborales específicas de riesgo
-Falta de condiciones laborales decentes
-Clima laboral inadecuado
-Existen diversos métodos que te pueden facilitar la identificación de problemas psicosociales en el ambiente de trabajo, por ejemplo:
-A través de un estudio cualitativo de clima laboral
-Estudio diagnóstico de seguridad y salud en el trabajo
-Estudio de cargas de trabajo.
-Análisis de participación
-Análisis de canales de comunicación
-Análisis de apoyo social.

La NOM-035-STPS-2018 contempla que los centros de trabajo que tengan entre 16 y 50 trabajadores, únicamente deberán realizar la identificación y análisis de los factores de riesgo psicosocial, incluyendo a todos los trabajadores. Mientras que, los centros de trabajo que tengan más de 50 trabajadores, deberán realizar la identificación y análisis de los factores de riesgo psicosocial y la evaluación del entorno organizacional, éstas se podrán realizar con una muestra representativa.

Al cumplir con la NOM-035-STPS estarás desarrollando una nueva cultura de bienestar laboral y creando programas de salud que ben
eficien a los empleados. 

Toma en cuenta que el manejo del estrés o del síndrome de burnout, así como el establecimiento de jornadas laborales flexibles, ayuda a la felicidad en el trabajo y a mejorar la productividad de tus empleados.

Desde el 2013, la Organización Internacional del Trabajo señaló que se han reducido los riesgos tradicionales a la seguridad en el trabajo, sin embargo, los empleados continúan con afectaciones a su salud, por lo tanto, el establecimiento de la NOM-035 es inminente. Así que con lo anterior, describiremos los aspectos más importantes sobre la NOM-035 la cual como esencia tienen la función de identificar, analizar y prevenir los factores de riesgo psicosocial, así como promover un entorno organizacional favorable en los centros de trabajo.  Las empresas deberán poner manos a la obra respecto a la atención de estos indicadores a partir del 1º de octubre 2019, pues “no hay fecha que no se cumpla, plazo que no se venza, ni deuda que no se pague”.

Un trabajo digno, con elevada productividad y colaborativo es posible en las empresas, con la aplicación de la NOM-035-STPS, pues ésta implica desarrollo del talento, capacitación, organización, respeto y conservación de un ambiente laboral sano. La aplicación de la NOM-035 es más que un clima laboral pues implica aspectos no solo de forma sino de fondo y que, cuidan o previenen comportamientos como el tortuguismo y el comportamiento apático de algunas personas tóxicas, puede impactar negativamente en los esquemas de trabajo. 

¿Qué aspectos abarca la NOM-035?:

1. Prevención de los factores de riesgo psicosocial.
2. Prevención de la violencia laboral.
3. Prevención de los factores de riesgo psicosocial que impulsan: el apoyo social, la difusión de la información y la capacitación.
4. Dispone de mecanismos seguros y confidenciales para la recepción de quejas por prácticas opuestas al entorno organizacional favorable y para denunciar actos de violencia laboral.
5. Reuniones para abordar las áreas de oportunidad de mejora, a efecto de atender los problemas en el lugar de su trabajo y determinar sus soluciones.
6. En lo relativo al apoyo social incluye actividades que permiten la mejora de las relaciones entre trabajadores, supervisores, gerentes y patrones para que puedan obtener apoyo los unos de los otros.
7. Promoción de la ayuda mutua y el intercambio de conocimientos y experiencias entre los trabajadores.
8. La integración, a través de la organización de actividades deportivas y/o culturales.
9. Respecto al reconocimiento en el trabajo, cuenta con mecanismos que permiten el reconocimiento del desempeño sobresaliente (superior al esperado) de los trabajadores.
10. Difusión de los logros de los trabajadores sobresalientes.

Para ponerse en contacto con CERTOLAB en consideración de los servicios de cumplimiento Norma 035, visite serviciomedicoempresas.com o llame a nuestra línea de servicio al cliente al +52 1 55 58 72 46 52.

Héctor Rafael Pérez Moreno
CERTOLAB Servicios Médicos para Empresas
+52 1 55 5872 4652
email us here
Visit us on social media:
Facebook
LinkedIn

CERTOLAB: Servicio Médico en Empresa, Norma 035 para Empresas


Source: EIN Presswire

Global Ophthalmic drugs Market Size Projected to Reach USD 37,700 Million By 2026: Facts & Factors

Ophthalmic Drug Market

Ophthalmic Drug Market

Global ophthalmic drugs market expected to reach USD 37,700 million by 2026 and is expected to grow at a CAGR of 4.6% from 2020 to 2026.

NEW YORK, UNITED STATES, February 20, 2020 /EINPresswire.com/ — Facts and Factors has authored “Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, and Others), By Disease Indication (Inflammation/ Infection, Retinal Disorders, Dry Eye, Glaucoma, Allergies, and Others), By Distribution Channel (Online Sales, Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026”.

According to the research report, the global ophthalmic drugs market in 2019 is over USD 27,000 million and is expected to reach around USD 37,700 million by 2026. The anticipated CAGR for the global ophthalmic drugs market is around 4.6% from 2020 to 2026.

Ophthalmic drugs, also referred to as eye medications, are solid, liquid, or semi-solid formulations that are intended to apply on the eyelids and conjunctiva. The drugs are certain emulsions, ointments, and/or active pharmaceutical ingredient(s).

Request Free Sample Copy of Research Report @ https://www.fnfresearch.com/sample/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by

(The sample of this report is readily available on request. Free report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

High prevalence of ocular disease cases likely to bolster the ophthalmic drug market

The visual impairment incidences have been surging considerably worldwide irrespective of the age group. This challenging situation has urged drug manufacturers and pharmaceutical companies to design and supply effective medications against this rapidly spreading disorder. Hence, the introduction of novel effective ophthalmic drugs bolsters the global ophthalmic drug market. Exposure to air and water pollution poses a greater risk to the eyes. Thus, surging the demand for the drugs and propelling the global ophthalmic drug market.

Ophthalmic drugs-associated side effects expected to hamper the ophthalmic market

Eye treatment involves a risky operation and has various side effects. In some cases, ophthalmic drugs fail to maintain the intraocular pressure of the eye while treatment. In most of the cases, the medicine may cause internal burning in the eye and/or temporary blurred vision. Owing to these attributes, the ophthalmic drugs market enters the declining phase.

Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Anti-infective drug class leads the global ophthalmic drug market

The anti-infective drug category, from the past few years, has been holding the dominating position in the global ophthalmic market. In 2019, the category accounts for more than one-third of the market share in terms of revenue. However, the anti-glaucoma drugs are projected to augment at a relatively faster CAGR throughout the forecast period.

Over-the-counter drug type accounts for higher sales and revenue share

Based on the type segment, ophthalmic drugs are categorized into prescription drugs and over-the-counter drugs. Among both, over-the-counter drug type holds around two-third share in the overall sales and revenue. However, the prescription drug category is anticipated to grow at higher CAGR between 2020 and 2026.

Browse the full “Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, and Others), By Disease Indication (Inflammation/ Infection, Retinal Disorders, Dry Eye, Glaucoma, Allergies, and Others), By Distribution Channel (Online Sales, Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Market Size, Statistical Research, Market Intelligence, Comprehensive Analysis, Historical Trends, and Forecasts, 2019–2026" report at https://www.fnfresearch.com/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by

Retail pharmacies expect better sales and revenue share during the forecast period

Despite the consecutive decline in the volume sales, the revenue generated by retail pharmacies is thrusting at a considerable rate. Based on the forecast, the drug category is likely to follow the same revenue growth trend. However, the hospital pharmacies category holds the leading position in the global market revenue generation.

Key market players

Some of the key players driving the global ophthalmic drugs market are Santen Pharmaceutical Co. Ltd., Bayer AG, ALLERGAN, Novartis AG, Pfizer Inc., Genentech Inc., Oxurion NV, Bausch Health Companies Inc., and Regeneron Pharmaceuticals Inc., among others.

In February 2019, Bausch Health Companies Inc.procures the patent medicine EM-100 investigational eye drop designed by Eton Pharmaceuticals EM-100 for the treatment of itching associated with the allergies in eyes.

Request Customized Copy of Report @ https://www.fnfresearch.com/customization/global-ophthalmic-drug-market-global-ophthalmic-drugmarket-by

(We customize your report according to your research need. Ask our sales team for report customization.)

The global ophthalmic drugs market is segmented as:

Global Ophthalmic Drugs Market: Type Segmentation Analysis

Over-the-Counter Drugs
Prescription Drugs

Global Ophthalmic Drugs Market: Drug Class Segmentation Analysis

Anti-Infective Drugs

Anti-Bacterial Drugs
Anti-Fungal Drugs
Anti-Viral Drugs
Others

Anti-Glaucoma Drugs

Prostaglandin Analogs
Alpha Agonist
BetaBlockers
Combined Medication
Others

Anti-inflammatory Drugs

Steroids
Non-Steroidal Anti-Inflammatory Drugs

Anti-Allergic Drugs
Others

Global Ophthalmic Drugs Market: Disease Indication Segmentation Analysis

Inflammation/ Infection
Retinal Disorders
Dry Eye
Glaucoma
Allergies
Others

Global Ophthalmic Drugs Market: Distribution Channel Segmentation Analysis

Online Sales
Retail Pharmacies
Hospital Pharmacies
Others

About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
Global Headquarters
Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal – 200120, China
Tel: +86 21 80360450
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com

Sanu Thomas
Facts & Factors
+1 386-310-3803
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Rosemary Barclay of Old Lyme Recommends Diet Changes for Combating Geriatric GERD

Gastroesophageal reflux disease (GERD), which is common among the population, can be treated naturally through diet according to Rosemary Barclay of Old Lyme.

OLD LYME, CT, USA, February 19, 2020 /EINPresswire.com/ — Almost everyone has had heartburn at some point in their life. It usually arises as a burning sensation in your chest after eating a heavy meal, but for some seniors, the issue can become severe. Rosemary Barclay, the founder, and owner of the Bonne Santé Wellness Center in Old Lyme, CT, explains that GERD is not only uncomfortable but also dangerous. The condition can lead to many other health complications such as asthma, chest pain, chronic cough, dental problems, dysphagia, indigestion, and vomiting.

For some people, a natural approach to treatment is possible through diet and lifestyle changes. While medications and over-the-counter remedies may temporarily relieve symptoms, the underlying issue will remain. Rosemary Barclay of Old Lyme, CT., recommends consulting a board-certified nutrition specialist to determine the best diet plan for your individual needs. However, there are some general foods to avoid.

Steer clear of foods that may trigger or worsen GERD symptoms. Rosemary Barclay of Old Lyme, CT, recommends removing caffeine, onions, alcohol, peppermint, citrus, carbonated beverages, and foods high in fat from your diet immediately. Everyone is different, which means some triggers and treatments will vary from person to person. A certified nutrition specialist will be able to discover the best treatment plan for you or your loved one.

Keep in mind that some foods may not need to be eliminated altogether, but instead just eaten earlier in the day. Geriatric patients will still be able to enjoy eating the things they love by making only a few simple modifications to their diets. Rosemary Barclay of Old Lyme, CT, notes that incorporating some foods may ease symptoms long-term.
Although you should avoid citrus fruits like oranges, grapefruits, and lemons, there are a variety of other fruits you can incorporate into your diet. Bananas, melons, apples, and pears can all be added to your diet. Additionally, leafy green vegetables are encouraged.

Rosemary Barclay of Old Lyme, CT., suggests GERD patients stick to lean proteins. Eggs or egg whites can be made for breakfast or boiled as a snack. Lean turkey and chicken are also a great option when grilled, broiled, or baked. Stay away from high-fat meals and fried foods, which can increase the risk of acid reflux.

Next, focus on eating complex carbohydrates like oatmeal and whole-grain bread. Finally, avoid and reduce the intake of saturated and trans fats. They are usually found in processed foods and dairy. Try getting your healthy fats from natural sources like fish, avocados, nuts, and seeds. GERD is sometimes associated with being overweight and carrying weight around your mid section so try to lose 10 lbs to alleviate symptoms.

About Rosemary Barclay of Old Lyme

Rosemary Barclay of Old Lyme believes that nutrition is fundamental to good health and affects many facets of well-being, including the skin, energy, immunity, mood, and performance. The Bonne Santé Wellness Center in Old Lyme, CT, offers solutions to problematic skin without the use of antibiotics or harsh chemicals.
She earned a bachelor’s degree and a Ph.D. in biochemistry in addition to becoming a board-certified nutrition specialist, certified esthetician, and acne specialist. Rosemary Barclay lives in Old Lyme, CT.

Caroline Hunter
Web Presence, LLC
+1 7862338220
email us here


Source: EIN Presswire

Ethicon Prosima TVT-O Case Progressing Forward in New York Federal Court

Ben Martin, Esq. and Laura Baughman, Esq. defend their client, an unfortunate victim of the Ethicon transvaginal mesh product, in New York.

The TVT-O and Prosima devices cause pudendal neuralgia…The magnitude of the risk of catastrophic pain makes these devices defective and unreasonably dangerous under the law.”

— Dr. Greg Vigna

SANTA BARBARA, CALIFORNIA, UNITED STATES, February 19, 2020 /EINPresswire.com/ — On February 11, 2020, Ben Martin, Esq. and Laura Baughman, Esq. together defended their client’s deposition in New York. The client was the unfortunate victim of the Ethicon transvaginal mesh product and suffered severe neurological injuries from the Prosima and TVT-O. The case is proceeding forward in the United States District Court for the Eastern District of New York (Case No: 2-19-cv-04021).

Greg Vigna, MD, JD, practicing physician, national pharmaceutical injury attorney, and Certified Life Care Planner discusses, “This case is one of many that my team is prosecuting outside the Multidistrict Litigation in West Virginia after the case was dismissed without prejudice after unsuccessful attempts at settlement in the MDL.” Vigna adds, “The MDL did a good job dealing with the issue of bladder and vaginal erosion, but little for women with disability caused by the catastrophic neurological injuries caused by transvaginal mesh. The cases we are prosecuting are those with symptoms consistent with pudendal neuralgia, obturator neuralgia, ilioinguinal neuralgia, and Complex Regional Pain Syndrome.”

The Prosima project was coined by Ethicon as “Project Mint” as it was designed to improve on the Prolift by eliminating the transobturator arms of the Prolift. An Ethicon internal document stated that the “Mint (had) potential to be positioned…for patients whose prolapse is not severe enough to warrant Prolift.”

Dr. Vigna states, “This case illustrates that Ethicon found it necessary to devise a transvaginal mesh device for pelvic organ prolapse (POP) that eliminates the transobturator arms of the Prolift but continues to market the TVT-O for the treatment of stress urinary incontinence (SUI) that is 45 cm long with arms that pass through the obturator fossa.” He adds, “Both the TVT-O and Prosima devices cause pudendal neuralgia, and the TVT-O cause obturator neuralgia. The magnitude of the risk of catastrophic pain makes these devices defective and unreasonably dangerous under the law.”

Greg Vigna, MD, JD through his California and Washington DC law firm along with national pharmaceutical injury law firms including national pharmaceutical injury trial law firm Martin Baughman from Dallas Texas represent many catastrophically injured women proceeding down the path to justice. Dr. Vigna says, “Our clients include those awaiting remand from the MDL to the Federal Courts across the country, those who have had cases dismissed without prejudice from the MDL, women in the New Jersey consolidated litigation awaiting their time in court, and newly injured women with catastrophic injuries with symptoms consistent with neuralgia across the country.”

For articles, video resources, and information, visit the Pudendal Neuralgia Educational Portal (https://pudendalportal.lifecare123.com/) or https://tvm.lifecare123.com/. Click here for information regarding sling related complications: https://tvm.lifecare123.com/slingebook.html

Greg Vigna
Greg Vigna, M.D., J.D., PLC
+1 800-761-9206
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Fertility Road Announces Exclusive Global Partnership With AI Company Life Whisperer

Life Whisperer Logo

Fertility Road Magazine

Fertility Road Magazine

A new partnership brings together two leaders in global fertility and paves the way for a leap forward in the way scientists choose the most viable embryos.

LONDON, UNITED KINGDOM, February 19, 2020 /EINPresswire.com/ — A new partnership brings together two leaders in the global fertility market and paves the way for a leap forward in the way scientists choose the most viable embryos in the IVF selection process.

Fertility Road is the world’s leading preconception platform for patients and has, over a decade been at the forefront of promoting emerging technologies, treatments and support to fertility patients across the globe. Working across five continents Fertility Road has an extensive network of clinic partners and interacted with over one million patients worldwide over the last year.

Life Whisperer, the fertility arm of AI healthcare company Presagen, which operates out of San Francisco, Adelaide (South Australia), and London are at the cutting edge of artificial intelligence fertility research and application. The latest application to roll out of the company’s rapidly emerging portfolio of femtech related technologies uses AI to analyze microscope images of embryos to assist clinicians to identify which embryo will likely lead to a pregnancy. By selecting the best embryo, Life Whisperer aims to shorten the time to pregnancy and improve outcomes for couples undergoing IVF treatment.

Life Whisperer recently completed an international clinical study across 12 clinics in 4 countries, including the United States, Australia, New Zealand, and Malaysia. The results demonstrated that the AI platform was 25 percent more accurate than highly trained and experienced embryologists in identifying the most viable embryos from the medical images of almost 1,600 patient cycles. The results of the research will be published in the top-ranking journal Human Reproduction in March 2020.

Life Whisperer is already commercially available for patients in Australia, and with the help of Fertility Road, it will be launching across Europe in March 2020. It is also currently seeking regulatory approval in the USA and Asia.

It is hoped this technology will help address the decline in fertility rates globally and increase success rates in fertility clinics which have remained fairly static over the last decade. The solution employs a combination of computer vision and machine learning techniques to help rank and identify healthy embryos for implantation, thereby significantly increasing the chances of a successful pregnancy.

During the IVF process, eggs are fertilized and develop into embryos. At this point, a clinician (embryologist) needs to decide which embryo to transfer into the patient. Manual selection of embryos is difficult, highly subjective and limited to what the eye can see down a microscope.

The Life Whisperer application allows clinicians to drag and drop single images of patient embryos taken immediately prior to transfer and returns an instant report as to the viability of each embryo to support the clinician’s decision about which embryo to transfer. Unlike other solutions, Life Whisperer’s web-based approach is non-invasive, does not require specialized time-lapse imaging hardware (although can operate on time-lapse images), requires little process change in the clinic, and can be delivered at a low cost to patients.

Fertility Road Co-Founder, Tone Jarvis-Mack says, “Life Whisperer has the technology, Fertility Road has the network. Together we hope to introduce this amazing technology to more fertility clinics around the world. We believe by using this enhanced tool Embryologists will, universally, be able to identify the best embryos and consequently increase the chances of treatment being successful. This technology is a game-changer and is one of the most exciting initiatives in IVF technology for some time”.

ABOUT LIFE WHISPERER

Life Whisperer offers new hope to improve pregnancy rates with a cloud-based AI system, trained on over 20,000 globally sourced 2D embryo images; a powerful basis for the Life Whisperer AI to quickly identify features invisible to the human eye.

This is why clinics around the world use Life Whisperer to help skilled embryologists identify the most viable embryos to focus on for their patients.

ABOUT FERTILITY ROAD
Launched in 2009 Fertility Road is the leading digital media brand for the fertility community. Our mission to guide men and women on their journey to start or extend their family. To educate, support and deliver the latest breaking fertility-related news stories to your first.

Tone Jarvis-Mack
Fertility Road
+44 20 7183 9882
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

See How Life Whisperer works – IVF technology to improve embryo selection


Source: EIN Presswire